Sun Pharma, other drug cos say innovative products to contribute substantially in future

By Sumit Blogs -

Sun Pharma, other drug cos say innovative products to contribute substantially in future

Sun Pharma, India’s largest drug maker, said it expects its innovative products to garner $1.5 billion in sales in the next 3-4 years.

Dilip Shanghvi, managing director of

said about 12%-13% of the company’s turnover comes from innovative products, and growing three times faster than the generics business.

Sun Pharma’s innovative pipeline includes specialty therapies such as psoriasis treatment Ilumya, ophthalmology drug Cequa, among others. The company is also investing in biosimilars and specialty drugs.

“We wish to become relevant also in innovative products,” said Shangvi, speaking at panel discussion with other top pharma executives at the Global Innovation Summit – 2021, organised by Indian Pharmaceutical Alliance (IPA).

Satish Reddy, co-chairman of Dr Reddy’s said 13 innovative products targeting immuno-oncology are in various stages of development. Reddy said the company wants to have 20% of its revenues coming from innovative products next 10 years.

Reddy said the government should give impetus on creating research and innovation hubs, triple or quadruple the research grants under the government’s National Research Foundation (NRF) and reinstate the weighted tax deduction to scientific research. The government in the budget 2021 announced an allocation of Rs 50,000 crore over a 5 year period to boost the research ecosystem in the country.

Nilesh Gupta, MD of Lupin said the company aspires to generate 20% of its revenues from innovation.

“It will take 10 years to get there, but that is the intent,” Gupta said.

Glen Saldanha, said his company has been pursuing drug discovery for two decades.

“We brought an innovative SGLT-2 inhibitor called Remogliflozin for treating diabetes to India, and developed 5-6 drugs both biologics and small molecules,” Saldanha said.

Indian drug companies who are basically built on copycat drugs or generics, are trying to shift gears to drug discovery and innovation. But the shift hasn’t been easy due to high risk and capital investment and low success rates.

Credits – Source – https://ift.tt/3DLkHHu

The post Sun Pharma, other drug cos say innovative products to contribute substantially in future appeared first on Stay in Gurgaon.

Comments

Post a Comment

Popular posts from this blog

Flat sale of flu drugs hints at no unusual rise in infections

By Sumit Blogs -
Image
By Economic Times – Flat sale of flu drugs hints at no unusual rise in infections Industry executives and chemists said the April sales data showed a month-on-month decline of 30-40%. But even though the lockdown is seen to be impacting sales of most drugs, the pattern for medicines for infections and flus is no different.Last Updated: Apr 30, 2020, 11.23 AM ISTAgenciesExperts said the decline in sales was primarily because of the lockdown and other restrictions which forced people to stay indoors. (This story originally appeared in on Apr 30, 2020)NEW DELHI: Sales of anti-infectives (antibiotics and antivirals), respiratory drugs, painkillers and analgesics — some key medicines used for influenza-like illnesses — have remained mostly unchanged in last three months (January to March), partly explained by the lockdown but also indicating no unusual rise in flu-type infections that might point to a wider and undetected spread of Covid-19. Sales of most medicines, including this set of
Read more

10YearsForSimha: Reasons behind film’s success

By Sumit Blogs -
Image
By Times of India – 10YearsForSimha: Reasons behind film’s success TIMESOFINDIA.COM | Last updated on – Apr 30, 2020, 06:00 ISTclose01/6Take a look at the reasons behind the film’s successDirected by Boyapati Srinu, the 2010 film Simha was a game-changer among Tollywood films that was lauded, not only for Nandamuri Balakrishna’s intense performance in the dual role but also the gripping narration of the filmmaker. Balayya and Nayanthara were seen on the big screen for the first time ever in the film. The action drama made a special place in the hearts of the audience because of its simple storytelling, superhit songs and unbeatable chemistry between the lead pair. The movie has completed a decade, but the essence is as fresh as it was back then. As the film clocks 10 years of its release, find out the reasons behind the massive success of the Balakrishna starrer.readmore02/6​Boyapati Srinu’s gripping narrationBefore Simha, Boyapati Srinu had delivered Bhadra (2005) and Tulasi (2007),
Read more

Hrithik-Saif’s Vikram Vedha hits a roadblock

By Sumit Blogs -
Image
The stage was about to be set for Hrithik Roshan and Saif Ali Khan’s ‘Vikram Vedha’ in Mumbai’s Film City. The material had reached. The artisans had been hired. But the lights have now been dimmed. Madhavan and Vijay Sethupathi’s hit movie Vikram Vedha’s Hindi remake will not go on floors by mid-July as per the original plan. The new delta virus of COVID has sent shudders down many spines and many films which were being laid out on an expansive scale have been either held back or shifted their shoots abroad. The first schedule of this Hrithik-Saif movie will now be shot abroad. A source says, “The Mumbai schedule will be done but later.” Adds the source, “It’s a call that was taken yesterday. It wasn’t an easy call to take, no doubt, but the fact that it’s going to be a costly set made the makers take the safer route rather than be sorry later.” When contacted, General Secretary of FWICE (Federation of Western India Cine Employees), Ashok Dubey, confirmed that the makers of ‘V
Read more